OsseoSeal™ Mineralized Allograft Syringe (0.5cc) | 50/50 Cortico-Cancellous

The OsseoSeal™ Allograft Syringe is designed for clinicians who prioritize precision, efficiency, and controlled handling in regenerative procedures. This delivery-ready system contains a 50/50 mineralized cortico-cancellous freeze-dried bone allograft (FDBA) blend in a pre-filled syringe format for direct-to-site placement.

Designed for Streamlined Surgical Workflow

Traditional particulate grafts often require transfer to a sterile dish for hydration before placement. The syringe format is designed to allow hydration and delivery within a single device, potentially reducing handling steps and supporting more controlled placement in precision-focused cases.

For clinicians who prefer open-dish preparation or larger volume formats, explore our FDBA vial configurations.

The OsseoSeal™ Allograft Syringe is indicated for use in guided bone regeneration (GBR), socket preservation, ridge augmentation, and localized defect management where a mineralized particulate scaffold is clinically appropriate. The 250–1000 µm particle range is selected for defect adaptation and handling consistency. The syringe format supports incremental delivery and may streamline chairside preparation compared to open mixing techniques.

Common Clinical Applications:

• Socket Preservation: Direct placement into extraction sites.
• Immediate Implant Gap Management: Incremental placement within peri-implant defects.
• Localized Ridge Augmentation: Controlled delivery within confined defect areas.

Professional Use Only: This human-derived tissue product is supplied sterile for single-patient use and is intended for licensed dental professionals only. Final case selection, surgical technique, and patient management decisions remain the responsibility of the treating clinician.

Fulfillment Notice: Orders are processed and shipped from our California facility for reliable nationwide US distribution.